Articles tagged "Outcome"

2019 American Transplant Congress
Timing Matters: Improving Prediction of Hospital Readmission Post Kidney Transplantation
J. Hogan¹, M. Arenson¹, S. Adhikary², K. Li¹, X. Zhang¹, R. Zhang¹, J. Valdez³, J. Sun³, A. B. Adams¹, R. E. Patzer¹
¹Transplant Research Center, Department of Surgery, Emory University, Atlanta, GA, ²Transplant Research Center, Department of Surgery, Georgia Technology Institute, Atlanta, GA, ³Georgia Technology Institute, Atlanta, GA
*Purpose: Hospital readmission rates after kidney transplant (KTx) are high and readmission is associated with graft failure and mortality. Predictive models of post-transplant readmission have…
2019 American Transplant Congress
Impact of Transplant Surgery Advanced Practice Providers in the Management of Pancreas Transplant Recipients
E. A. Herriman, J. M. Sharp, K. J. Brown, J. R. Montgomery, J. C. Magee, J. D. Punch, R. S. Sung, K. J. Woodside
Section of Transplantation, Department of Surgery, University of Michigan, Ann Arbor, MI
*Purpose: Transplant surgery advanced practice providers (APPs) roles and responsibilities vary widely between different transplant centers. In an effort to standardize care for the pancreas…
2019 American Transplant Congress
Antirejection Efficacy in De Novo Renal Transplant Recipients Receiving Everolimus with a Reduced-Exposure Calcineurin Inhibitor-Based Regimen: 24-Month Results from the TRANSFORM Study
H. Tedesco Silva¹, F. Citterio¹, M. Henry¹, T. R. Srinivas¹, Y. Watarai¹, S. Steinberg¹, N. Basic-Jukic¹, V. D. Garcia¹, E. Mor¹, V. R. Peddi¹, P. Narvekar², M. P. Hernandez Gutierrez², P. Bernhardt², J. Pascual¹
¹TRANSFORM Study Group, Basel, Switzerland, ²Novartis Pharma AG, Basel, Switzerland
*Purpose: To compare the antirejection efficacy outcomes of an everolimus+reduced-exposure CNI (EVR+rCNI) vs mycophenolic acid+standard-exposure CNI (MPA+sCNI) regimen in renal transplant recipients (RTxRs) from the…
2019 American Transplant Congress
Diminishing Scientific Registry of Transplant Recipients Risk-Adjusted Mortality: Reaction to Flagging, Artifact of Modeling, or Both?
J. A. Gregg¹, K. L. Womer¹, A. Santos¹, S. J. Moore², K. A. Andreoni³
¹Division of Nephrology, Hypertension, and Renal Transplantation, University of Florida, Gainesville, FL, ²Shands Transplant Center, University of Florida, UF Health Shands, Gainesville, FL, ³Department of Surgery, University of Florida, Gainesville, FL
*Purpose: To examine longitudinal trends in SRTR risk-adjusted patient and graft survival rates.*Methods: Current, and archived versions of The Scientific Registry of Transplant Recipients (SRTR)…
2019 American Transplant Congress
Maternal and Pregnancy Outcomes after Living Donor Nephrectomy in a Multistate Cohort
G. S. Lee¹, R. X. Wang², D. O. Walls³, P. P. Reese⁴, D. S. Goldberg⁴, P. L. Abt¹
¹Surgery, Hospital of the University of Pennsylvania, Philadelphia, PA, ²Sidney Kimmel Medical College, Philadelphia, PA, ³Surgery, Rutgers Robert Wood Johnson, New Brunswick, NJ, ⁴Medicine, Hospital of the University of Pennsylvania, Philadelphia, PA
*Purpose: Studies have demonstrated increased risk of preeclampsia for pregnancies after kidney donation in homogenous populations or single-center studies. Our study aims to delineate maternal…
2019 American Transplant Congress
Improving Living Donor Follow Up
L. Aronoff, V. Nair, C. Flores, M. Bhaskaran, E. Molmenti, A. Fahmy, M. Zhou, E. Grodstein, D. Campbell, C. Literello, L. Teperman
Renal Transplant, Northwell Health, Manhasset, NY
*Purpose: OPTN requires transplant centers follow living donors (LDs) at 6 months, 1 year and 2 years post donation with a minimum threshold of 95%…
2019 American Transplant Congress
Conversion to Belatacept in Kidney Transplant Recipients with Systemic Lupus Erythematosus
I. Carrión Barberà, M. C. Fajardo, D. Tsapepas, J. Gartshteyn, A. Askanase, H. E. Fernandez
Columbia University MC, New York, NY
*Purpose: Lupus nephritis (LN) results in the need for renal replacement therapy (RRT) in 10-30% of LN pts and 30% receive a kidney transplant (KT).…
2019 American Transplant Congress
Personality Traits of Liver Transplant Candidates – Unappreciated Challenges
D. Ladner¹, J. Lai², A. N. Hall¹, E. D. Bastarache¹, A. Daud¹, T. Bogg³, A. Lebsack¹, T. Kalume¹, D. Mroczek¹
¹Northwestern University, Chicago, IL, ²UCSF, San Francisco, CA, ³Wayne State University, Chicago, IL
*Purpose: Liver transplant candidates are chronically ill, requiring complex medical care prior to and after transplant to optimize outcomes. Conscientiousness is one of the Big…
2019 American Transplant Congress
Changing Education Paradigms: Training Fellows for High Stake Procedures
T. Rice¹, H. Lewis¹, M. Cuffy¹, L. Ratner², T. Diwan¹
¹Department of Surgery, University of Cincinnati Medical Center, Cincinnati, OH, ²Department of Surgery, Columbia University, New York, NY
*Purpose: Living kidney donation is unique, as healthy patients are placed at risks inherent with major surgery without physical benefit. The procedure receives intense scrutiny…
2019 American Transplant Congress
The Clinical Outcomes of Kidney Transplant Recipients with Early Graft Failure: A Nationwide Study in South Korea
Y. Kim¹, S. Kwon¹, S. Park¹, J. Moon¹, J. Seon¹, J. Kim¹, M. Yu², K. Han³, D. Kim¹, Y. Kim¹, H. Lee¹
¹Internal Medicine, Seoul National University Hospital, Seoul, Korea, Republic of, ²Internal Medicine, Hanyang University Medical Center, Seoul, Korea, Republic of, ³Medical Statistics, Catholic University of Korea, Seoul, Korea, Republic of
*Purpose: Despite the graft outcome has been steadily improved over the years, early graft failure (EGF) poses a significant threat to kidney transplant (KT) recipients.…